Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 40 Schemes (10.55%)
Foreign Institutions
Held by 86 Foreign Institutions (4.3%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
15 Million
(Quarterly Results - Jun 2023)
Net Profit:
-109 Million
Pharmaceuticals & Biotechnology
USD 2 Million ()
0
NA
0.00%
-0.36
-999,999.00%
-0.01






